Non-nucleosides are a powerful option for treating HIV, but cross-resistance can mean you only get one bite of the cherry. This is the final instalment in a three-part series looking at key drug classes.
Nevirapine
News and treatments briefs
From the February 2004 issue of Positive Living
HIV-related news in brief from the Feb-Mar 2004 edition of Positive Living. The power of one
From the December 2003 issue of Positive Living
We all want simpler treatment regimens with fewer side effects and no meal restrictions, right? Well how does once-a-day treatment sound? As PAUL KIDD reports, it may be closer than you think. News and treatments briefs
From the June 2003 issue of Positive Living
HIV-related news in brief from the June-July 2003 edition of Positive Living. Retro roundup
From the April 2003 issue of Positive Living
The 10th Conference on Retroviruses and Opportunistic Infections took place in Boston in February. This annual conference is a very highly regarded event with a strong scientific focus, so it often produces a number of important advances in our understanding of HIV and its treatment, and this year was no exception.